Monte Rosa Therapeutics, Inc.
Ticker: 1826457
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 4.21-67.0% | 12.77-44.9% | 23.19-72.7% | 84.93+821.1% | 9.22+96.2% | 4.70+343.4% | 1.06 |
| Total Income | 4.21-67.0% | 12.77-44.9% | 23.19-72.7% | 84.93+821.1% | 9.22+96.2% | 4.70+343.4% | 1.06 |
| EXPENSES | |||||||
| Expenditure | 54.24+18.6% | 45.74+18.0% | 38.75-5.2% | 40.89+14.4% | 35.74-4.3% | 37.34+3.7% | 36.01 |
| Tax | 0.05+101.6% | -3.18-365.0% | 1.20+46.3% | 0.82+1071.4% | 0.07-72.0% | 0.25+212.5% | 0.08 |
| PROFIT | |||||||
| PBT | -44.45-46.9% | -30.26-172.6% | -11.10-123.3% | 47.71+300.5% | -23.79+20.9% | -30.06+5.7% | -31.89 |
| Net Profit | -44.50-64.3% | -27.08-120.2% | -12.30-126.2% | 46.89+296.5% | -23.86+21.3% | -30.31+5.2% | -31.97 |
| KEY METRICS | |||||||
| OPM % | -100.00% | -100.00%-32.94pp | -67.06%-118.91pp | 51.85%+151.85pp | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00%-46.99pp | -53.01%-108.21pp | 55.20%+155.20pp | -100.00% | -100.00% | -100.00% |
Corporate Events
Board MeetingGLUE
202611Jun
Board Meeting
Annual Meeting of Stockholders to elect three Class II direc…
SEC Filing ↗